Continuous administration of adenosine to reduce pulmonary vascu

Details Continuous administration of adenosine to reduce pulmonary vascu Continuous administration of adenosine to reduce pulmonary vascu

1990-12-19

1992-04-14

Brown, Johnnie R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

536 26, A61K 3170, C07H 19167

Patent

active

051048590

ABSTRACT:
This invention is concerned with the use of adenosine as an agent for the treatment of human beings. More particularly, this invention is concerned with the administration of adenosine to human patients by continuous intravenous infusion for, inter alia, control of blood pressure, use as a selective vasodilator, decreasing pulmonary vascular resistance, treating acute pulmonary hypertension in conjunction with idiopathic respiratory distress syndrome, in diagnosing pulmonary hypertension in conjunction with cardiac septum defects, in percutaneous transluminal angioplasty (PTCA), in coronary thrombolysis (CTL), and in radionucleide scintography.

REFERENCES:
patent: 3823234 (1974-07-01), Mauvernay
patent: 3845205 (1974-10-01), Maguire et al.
patent: 4007268 (1977-02-01), Voorhees
patent: 4088756 (1978-05-01), Voorhees
patent: 4364922 (1982-12-01), Berne et al.
patent: 4605644 (1986-08-01), Foker
patent: 4673563 (1987-06-01), Berne et al.
Masters et al., Thorac. Cardiovas. Surgeon, 30, 14-20 (1982).
Silverman et al., Chest, 83(56), 787-792.
Sollevi et al., Acta Physiol. Scand., 120, 171-176 (1984).
Kalaja, Chem. Abstr., 33:236.sup.2 (1939).
DuBois-Ferriere et al., Chem. Abstr., 40:1926.sup.7 (1946).
Muschaweck et al., Chem. Abstr., 53:12484b (1959).
Kassell et al., Chem. Abstr., 98:100,933y (1983).
Sollevi et al., Chem.Abstr., 99:206,877u (1983).
Nuta, Chem. Abstr., 101:116,749j (1984).
Sollevi et al., Anesthesiology, 59(3), p. A9 (1983).
Strange et al., Acta Anesthesiol. Scand., 33, 199-203 (1989).
Bloor et al., Anesthesiology, 63, 517-525 (1985).
Lagerkranser et al., Anesthesiology, 60, 547-552 (1984).
Kassell et al., J. Neurosurg., 58, 69-76 (1983).
Fredholm et al.(I), J. Physiol., 313, 351-367 (1981).
Fredholm et al. (II), Clinical Physiol., 6, 1-21 (1986).
Sollevi et al., Acta Physiol. Scand., 120, 171-176 (1984).
Sollevi et al., Anesthesiology, 61, 400-405 (1984).
Fukunaga et al., Anesthesia and Analgesia 61, 273-278 (1982).
Fukunaga et al., Anesthesiology, 57(3), p. A65 (1982).
Leppo et al., Circulation, 63(3), 637-639 (1981).
Born et al., Nature 205, 678-680 (1965).
Sollevi, "Cardiovascular Effects of Adenosine in Man," in Anti-Asthma Xanthines and Adenosine, Proceeding of a Symposium in Copenhagen, Andersson and Persson eds., Excepta Medica, Princeton, NJ, 1985, see pp. 403-409.
Owall et al., Anesthesia and Analgesia, 66, 229-2345 (1987).
Torssell et al., Anesthesiology, 63(3A), p. A34 (1985).
Sollevi et al., Scand. J. Thor. Cardiovasc Surg., 19(2), 155-159 (1985).
Quantitative Thallium-201 Redistribution with a Fixed Coronary Stenosis in Dogs, Leppo et al., vol. Circulation 63, No. 3, Mar. 1981, pp. 632-639.
Comparative Effectiveness of Adenosine Analogues as Inhibitors of Blood-Platelet Aggregation and as Vasodilators in Man, Born et al., Nature, Feb. 13, 1965, vol. 205, pp. 678-680.
"Cardiovascular Effects of Adenosine in Man", Anti-Asthma Xanthines and Adenosine, Proceedings of a Symposium in Copenhagen, Excerpta Medica (1985).
Fredholm & Sollevi, J. Physiol., 313:351-362 (1981).
Sollevi et al., Acta Physiol., Scandi, 120:171-176 (1984).
Fredholm & Sollevi, Clinical Physiology, 6:1-21 (1986).
Sollevi et al., Scandi J. Thor. Cardiovasc. Surg., 19:155-159 (1985).
T. N. Masters et al., Thoracic and Cardiovascular Surgeon, vol. 30, No. 1, issued 1982 (New York).
N. A. Silverman et al., Chest, vol. 83, No. 5, issues 1983 May (Chicago).
Chemical Abstracts, vol. 33 (1939).
Chemical Abstracts, vol. 40 (1946).
Chemical Abstracts, vol. 53 (1959).
Chemical Abstracts, vol. 99 (1983).
Chemical Abstracts, vol. 101 (1984).
Thoracic and Cardiovascular Surgeon, vol. 30, No. 1 issued 1982 (New York), T. N. Masters et al., "Platelet Anti-Aggregating and Hemodynamic Effects of Adenosine and Prostaglandin E,", see pp. 14-20, especially p. 14 and pp. 18-19 (Discussion).
Chest, vol. 83, No. 5, issued 1983 May (Chicago), N. A. Silverman, et al., "Beneficial Metabolic Effect of Nucleoside Augmentation on Reperfusion Injury Following Cardioplegic Arrest", see pp. 787-792, especially p. 787 (abstract), p. 788, first col., second para and p. 791.
Acta Physiologica Scandinavica, vol. 120, No. 2, issued 1984 (Stockholm), A. Sollevi et al., "Relationship Between Arterial and Venous Adenosine Levels and Vasodilation during ATP-and Adenosine-Infusion in Dogs", see pp. pp. 171-176, esp. 171 and p. 172, first col., line 19-24 after the table.
Chemical Abstracts, vol. 33 (1939), Abstract No. 236.sup.2, Acta Med Scand, Suppl 89, 239-244 (1938).
Chemical Abstracts, vol. 40 (1946), Abstract No. 1926.sup.7, Helv Physiol Pharmacol Acta 3, 621-636 (1945) (in French).
Chemical Abstracts, vol. 53 (1959), Abstract No. 124 84b, Arch exptl Pathol Pharmakol 236, 226-229 (1959).
Chemical Abstracts, vol. 98 (1983), Abstract No. 100 933y, J. Neurosurg 1983, 58 (1), 69-76 (Eng).
Chemical Abstracts, vol. 99 (1983), Abstract No. 206 877u, Acta Physiol Scand 1983, 119 (3), 225-230 (Eng).
Chemical Abstracts, vol. 101 (1984), Abstract No. 116 749j, Rom RO 82,025.
Anesthesiology, vol. 59, No. 3 Sep. 1983, A Sollevi et al., "Cardiovascular Effects of Adenosine During Controlled Hypotension".
Acta Anesthesiol Scand 1989:33:199-203, K. Stange et al., "Effects of Adenosine-Reduced Hypotension on Cerebral Blood Flow".
Anesthesiology 63:517-525, 1985 Bloor et al., "Myocardial Hemodynamics During Induced Hypotension: A Comparison Between Sodium Nitroprusside and Adenosine Triphosphate".
Fukunaga et al., (I) "Hypotensive Effects of Adenosine and Adenosine Triphosphate Compared with Sodium Nitroprusside, Anesth. Anal., vol. 61(3), 273-278 (1982).
Fukunaga et al., (II) "ATP-Induced Hypotensive Anesthesia During Surgery," Anesthesiology, vol. 57 (3), p. A65 (1982).

Affiliated with

Also associated with

Rating

Continuous administration of adenosine to reduce pulmonary vascu does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Continuous administration of adenosine to reduce pulmonary vascu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Continuous administration of adenosine to reduce pulmonary vascu will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2349371